Columbus Circle Investors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Columbus Circle Investors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$58.3M	Sell	797,244 -220,673	-22%	-$16.4M	2.56%	4
2020 Q3	$79.1M	Sell	1,017,917 -63,619	-6%	-$4.38M	3.44%	1
2020 Q2	$60.1M	Buy	1,081,536 +165,469	+18%	+$7.08M	2.42%	3
2020 Q1	$27.1M	Sell	916,067 -8,578	-0.9%	-$290K	1.49%	13
2019 Q4	$33.5M	Buy	924,645 +234,097	+34%	+$7.18M	1.44%	18
2019 Q3	$18.8M	Buy	690,548 +30,294	+5%	+$783K	0.69%	60
2019 Q2	$15.9M	Buy	660,254 +205,697	+45%	+$5.22M	0.42%	77
2019 Q1	$12M	Buy	+454,557	New	+$10.8M	0.31%	90

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Columbus Circle Investors's HZNP Position: Q4 2020 in Review

Columbus Circle Investors reduced its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 22% in Q4 2020, selling an estimated $16.4M and leaving 797,244 shares worth $58.3M. The position accounts for 2.56% of the portfolio, ranked #4.

Columbus Circle Investors first reported a position in HZNP in Q1 2019 and has held it in 8 quarters since. The position peaked at $79.1M in Q3 2020. 497 funds tracked by Wall St. Rank hold HZNP as of Q4 2020.

Columbus Circle Investors held 797,244 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $58.3M as of Q4 2020.
Columbus Circle Investors sold 220,673 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2020, an estimated $16.4M.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 2.56% of Columbus Circle Investors's portfolio in Q4 2020, its #4 holding.
Columbus Circle Investors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and has held it in 8 quarters since.
Columbus Circle Investors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $79.1M in Q3 2020.
497 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2020.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.